|1.||Kojima, Masami: 3 articles (05/2011 - 08/2003)|
|2.||Yamazaki, Yoshinobu: 3 articles (05/2011 - 08/2003)|
|3.||Tomiyama, Yoshitaka: 3 articles (05/2011 - 08/2003)|
|4.||Wanajo, Isao: 2 articles (05/2011 - 12/2005)|
|5.||Shibata, Nobuo: 2 articles (12/2005 - 08/2003)|
|6.||Tadachi, Mariko: 1 article (12/2005)|
|7.||Kobayashi, Mamoru: 1 article (12/2005)|
|8.||Akahane, Masuo: 1 article (08/2003)|
|9.||Akiyama, Katsuyoshi: 1 article (08/2003)|
|10.||Murakami, Makoto: 1 article (08/2003)|
05/01/2011 - "In the anesthetized pigs, all 4 drugs reduced the unilateral ureteral obstruction-induced elevated intraureteral pressure in a dose-dependent manner, with KUL-7211 reducing it with a lower hypotensive effect than either isoproterenol or terbutaline. "
05/01/2011 - "To compare the potency and ureteral selectivity of the selective β(2)/β(3)-adrenoceptor agonist KUL-7211 with those of the nonselective β-adrenoceptor agonist isoproterenol, selective β(2)-adrenoceptor agonist terbutaline, and selective β(3)-adrenoceptor agonist CL-316243, we performed the study using an isolated porcine ureter and a porcine model of acute unilateral ureteral obstruction. "
05/01/2011 - "Ureteral selectivity of intravenous β-adrenoceptor agonists in pig model of acute ureteral obstruction: comparison of KUL-7211, a selective β2/β3 agonist, with isoproterenol, terbutaline, and CL-316243."
05/01/2011 - "A selective β(2)/β(3)-adrenoceptor agonist, such as KUL-7211, warrants additional investigation as a potentially useful drug for the promotion of stone passage in patients with urolithiasis."
12/01/2005 - "Possibly, KUL-7211 might be useful for promoting stone passage and relieving ureteral colic in urolithiasis patients."
08/01/2003 - "KUL-7211 may be a novel and useful medication for relieving ureteral colic and promoting stone passage in urolithiasis patients."